Hyperion DeFi, Inc.
HYPDNASDAQHealthcareMedical - Devices
Latest quote
$3.17
+$0.04 · +1.27%
HYPD company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Sell
Trim exposure — unfavorable risk-reward
Valuation
51
Fair Value
Momentum
20
Strong Down
Sentiment
46
Mixed
Risk resilience
18
Extreme Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
Company websiteOperating from the United States, Hyperion DeFi, Inc. is a company undergoing a significant shift from its foundational work in ophthalmic drug-delivery, known as Optejet. Its current trajectory involves establishing itself as the inaugural U.S. firm on Nasdaq to hold a cryptocurrency treasury, predominantly denominated in HYPE tokens originating from the Hyperliquid blockchain. Furthermore, Hyperion DeFi oversees the "Kinetiq × Hyperion" validator, persists with its decentralized finance (DeFi) staking strategies, and continues to advance its Optejet UFD™ technology for ocular health.
- Industry
- Medical - Devices
- Sector
- Healthcare
- Headquarters
- US
- CEO
- Hyunsu Jung
- Listed since
- Jan 25, 2018
- Employees
- 9
Market position
- Volume
- 833.43K
- 1.64× average
- Average volume
- 507.74K
- Average daily volume
- Market cap
- 48.2M USD
- Beta
- 2.5
- Market reference 1
Analyst ratings
Third-party consensus; not a GoAI recommendation.
Recent analyst actions
HYPD peers
Continue in GoAI
Research HYPDresearch.disclaimer